Atlas Trials

Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration.

Clinical trial NCT05056025 · UNKNOWN

Trial details

NCT number
NCT05056025
Sponsor
Institut de la Macula y la Retina
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
AMDSoft DrusenReticular PseudodrusenDrusen Stage Macular DegenerationDrusen (Degenerative) of Macula, Bilateral
Start date
2020-12-02
Primary completion
2023-01-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.